Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

Autori
Categoria Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
To evaluate the serum neutralizing antibody titre in cancer patients undergoing active treatment against variants (VOC) before and after the third dose of BNT162b2 COVID-19 vaccine.
Epistemonikos ID: 2a166cfa3352de63802be5847d51218e1c0f22dd
First added on: Mar 29, 2024